Waldencast plc (NASDAQ:WALD – Get Free Report) saw a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 439,900 shares, a decrease of 35.1% from the October 31st total of 678,200 shares. Based on an average daily volume of 210,100 shares, the days-to-cover ratio is currently 2.1 days. Approximately 1.9% of the company’s shares are sold short.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on WALD shares. Telsey Advisory Group restated an “outperform” rating and set a $6.00 target price on shares of Waldencast in a research report on Monday, November 18th. DA Davidson raised their price target on Waldencast from $6.50 to $7.25 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Canaccord Genuity Group started coverage on Waldencast in a research report on Friday, October 25th. They issued a “buy” rating and a $5.00 price objective on the stock. Finally, Canaccord Genuity Group increased their target price on Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a research note on Friday, November 22nd.
Check Out Our Latest Stock Report on WALD
Waldencast Price Performance
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Renaissance Technologies LLC purchased a new stake in shares of Waldencast in the 2nd quarter worth $239,000. Marshall Wace LLP purchased a new stake in Waldencast in the second quarter worth about $37,000. Cubist Systematic Strategies LLC purchased a new stake in Waldencast in the second quarter worth about $85,000. Simplicity Wealth LLC grew its holdings in Waldencast by 416.2% during the 3rd quarter. Simplicity Wealth LLC now owns 77,080 shares of the company’s stock worth $281,000 after acquiring an additional 62,148 shares in the last quarter. Finally, Bleakley Financial Group LLC increased its position in Waldencast by 75.2% during the 3rd quarter. Bleakley Financial Group LLC now owns 26,297 shares of the company’s stock valued at $96,000 after purchasing an additional 11,288 shares during the period. Institutional investors own 41.97% of the company’s stock.
About Waldencast
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Featured Stories
- Five stocks we like better than Waldencast
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- ESG Stocks, What Investors Should Know
- 3 Penny Stocks Ready to Break Out in 2025
- 3 Stocks to Consider Buying in October
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.